Anastasia Khvorova

Boulder, CO, United States of America

Anastasia Khvorova

This inventor holds 207 USPTO granted patents and 105 published patent applications, plus 10 CIPO patents and 26 EPO patents, primarily in Oligonucleotide Modulation (CPC class C12N2310-14). Top assignees: Dharmacon, Inc., University of Massachusetts, Thermo Fisher Scientific Gmbh. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anastasia Khvorova. Retrieved from https://idiyas.com/inventor/anastasia-khvorova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 207 

% Patents Active = 57.5

 

 

Average Co-Inventor Count = 5.1

ph-index = 47

Forward Citations = 5,126(Granted Patents)

Forward Citations (Not Self Cited) = 1,455(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Boulder, CO (US) (2001 - 2015)
  • Northborugh, MA (US) (2018 - 2020)
  • Northborough, MA (US) (2012 - 2021)
  • Westborough, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 2001-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oligonucleotide
siRNA
Gene Expression
Pharmacokinetics
Tissue Delivery
SARS-CoV-2
RNA Interference
Bioactive Conjugates
Exosomes
Stability
Modified Oligonucleotides
Oligonucleotide Compounds
207 patents (USPTO):Explore Patents

Title: Anastasia Khvorova: Pioneering Molecular Biologist with an Impressive Patent Portfolio

Introduction:

Anastasia Khvorova is a renowned molecular biologist who has made significant contributions to the field. Her impressive career is marked by numerous achievements and accolades. With a Ph.D. in Molecular Biology from the Institute of Molecular, Khvorova's expertise lies in the development of innovative and efficient oligonucleotide compounds for the treatment of various disorders. This article delves into Khvorova's latest patents, career highlights, collaborations, and notable contributions to the field.

Latest Patents:

Anastasia Khvorova has an impressive patent portfolio, with a total of 186 patents to her name. Some of her latest patents include:

1. Conjugated Oligonucleotides: Khvorova's research focuses on the development of conjugated oligonucleotides characterized by efficient and specific tissue distribution. These compounds show great potential for targeted drug delivery and have significant implications for therapeutic applications.

2. Optimized Anti-FLT1 Oligonucleotide Compounds: This patent highlights Khvorova's work on novel targets for angiogenic disorders, such as preeclampsia. By optimizing anti-FLT1 oligonucleotide compounds, she aims to improve the treatment outcomes for patients suffering from these conditions. The patent also includes novel oligonucleotides and methods of using them for the treatment of angiogenic disorders.

Career Highlights:

Throughout her illustrious career, Khvorova has achieved several notable milestones. She has made significant contributions to the development and application of oligonucleotide-based therapeutics. Some of her career highlights include:

1. Research at Dharmacon, Inc.: Khvorova worked at Dharmacon, Inc., a renowned provider of RNA and gene expression tools. During her time there, she made groundbreaking discoveries and advancements in the field of oligonucleotide therapeutics.

2. Collaboration with the University of Massachusetts: Khvorova has collaborated closely with the University of Massachusetts, furthering research and development efforts in molecular biology. Her collaborations with renowned scientists and researchers have led to exciting breakthroughs and advancements in the field.

Collaborations:

Anastasia Khvorova's work has been enriched by collaborations with other talented individuals. Some notable colleagues she has worked with include:

1. Devin Leake: Khvorova has collaborated with Devin Leake, a prominent scientist and expert in the field of RNA interference. Together, they have made significant strides in the development of RNA-based therapeutics.

2. William Marshall: Another colleague Khvorova has collaborated with is William Marshall, an esteemed molecular biologist. Their joint efforts have resulted in significant contributions to the understanding and application of oligonucleotide-based therapies.

Conclusion:

Anastasia Khvorova's career as a molecular biologist has been characterized by numerous achievements and accolades. Her groundbreaking research and patent portfolio highlight her dedication and expertise in the development of novel oligonucleotide-based therapeutics. Through collaborations with renowned institutions and talented colleagues, Khvorova continues to pave the way for innovative solutions in the field of molecular biology. Her contributions have the potential to revolutionize the treatment of various disorders and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…